Table 2.

Participant disease characteristics and late effects, by trajectory of social isolation

Disease characteristics and late effects		All, n = 30 (%)	Never isolated, n = 11 (%)	Diminished isolation, n = 9 (%)	Persistent isolation, n = 4 (%)	Delayed isolation, n = 6 (%)
Age at first diagnosis	0–4	27	18	45	0	33
	5–9	33	18	33	50	50
	10+	40	64	22	50	17
Type of cancer	Leukemia or lymphoma	53	55	56	25	67
	Brain tumor	20	0	22	75	17
	Sarcoma (not including brain)	20	27	22	0	17
	Other solid tumours	7	18	0	0	0
Treatments	Radiation therapy	90	82	89	100	100
	Chemotherapy	97	100	100	75	100
	Surgery	37	27	22	75	50
	Bone marrow transplant	3	9	0	0	0
Late effects and health problems	Second cancer	30	9	22	50	17
	Learning difficulties or cognitive impairment	30	9	44	50	33
	Impaired growth and development	43	0	44	100	17
	Bone, joint, or soft tissue late effects	40	27	56	75	33
	Visual impairment	23	18	78	50	17
	Hearing impairment	27	9	44	25	17
	Impaired sexual development or infertility	30	0	33	50	50
	Cardiovascular late effects	17	36	22	25	33
	Respiratory late effects	17	27	22	0	0
	Dental late effects	13	27	22	0	0
	Endocrine late effects	30	18	11	25	0
	Digestive late effects	20	18	56	50	0
	Anxiety or depression	37	0	44	100	50